Dabrafenib plus trametinib in patients with BRAF V600-mutant melanoma brain metastases (COMBI-MB): a multicentre, multicohort, open-label, phase 2 trial
Titel:
Dabrafenib plus trametinib in patients with BRAF V600-mutant melanoma brain metastases (COMBI-MB): a multicentre, multicohort, open-label, phase 2 trial
Auteur:
Davies, Michael A Saiag, Philippe Robert, Caroline Grob, Jean-Jacques Flaherty, Keith T Arance, Ana Chiarion-Sileni, Vanna Thomas, Luc Lesimple, Thierry Mortier, Laurent Moschos, Stergios J Hogg, David Márquez-Rodas, Iván Del Vecchio, Michele Lebbé, Céleste Meyer, Nicolas Zhang, Ying Huang, Yingjie Mookerjee, Bijoyesh Long, Georgina V